Optimization of the conditions for preservation of induced sputum: influence of freezing on cellular analysis.

BACKGROUND: Induced sputum (IS) analysis is a noninvasive, valid, and reproducible method for evaluating airway inflammation. It has been suggested that freezing of IS samples in order to delay analysis is feasible. However, the optimal conditions for preservation of IS samples have not been determined. OBJECTIVES: To determine optimal freezing conditions of IS samples, ensuring adequate specimen quality for assessment of cell viability, total cell count, and differential cell count. SUBJECTS AND METHODS: Twenty-one subjects were enrolled: 6 healthy control subjects, 5 patients with allergic rhinitis, 5 patients with mild asthma, and 5 patients with severe asthma. Each came to the laboratory once for IS sampling. Cell plugs were homogenized with dithiothreitol and separated into 12 aliquots. Viability and total and differential cell counts were determined for each aliquot. Bovine serum albumin (BSA) with dimethylsulfoxide (DMSO) was added to half of the aliquots, and fetal bovine serum (FBS) with DMSO was added to the other half. One half of the aliquots containing BSA or FBS were frozen at -20 degrees C, and the other half were frozen at - 80 degrees C. After 3, 7, or 10 days, samples were thawed and total cell counts, viability, and differential cell counts were assessed. RESULTS: Slide quality and total cell counts did not vary significantly according to freezing duration, temperature, or medium when compared to nonfrozen control samples. With FBS at -80 degrees C, cell viability did not vary significantly between control samples and freezing for 3, 7, and 10 days (59% vs 54%, 59% vs 54%, and 58% vs 54%, respectively; p > 0.05), whereas every other condition showed a significant decrease. Freezing did not affect the eosinophil percentage significantly. CONCLUSION: Freezing of IS samples in FBS with DMSO at - 80 degrees C allows adequate preservation of IS specimens. Samples can be kept for at least 10 days in those conditions without significantly altering total cell counts, viability, and eosinophil percentage.

Lower airway inflammatory responses to high-intensity training in athletes.

PURPOSE: There is an increased prevalence of asthma and airway hyperresponsiveness in elite athletes, particularly in swimmers. High intensity exercise may induce airway inflammation and subsequent remodelling in these subjects. Our aim was to evaluate the effects of high-intensity training on induced-sputum cell populations in elite athletes. METHODS: Swimmers and runners with hyperresponsive airways (SH and RH), defined by a provocative concentration of methacholine inducing a 20% decrease in FEV1 (PC20) <16 mg/ml or with normoresponsive airways (PC20 > 16 mg/ml; SN, RN) to methacholine were enrolled. The mean PC20 was 2.27 mg/ml in SH (n=12), 32.2 in SN (n=10), 3.25 in RH (n=10) and 41.5 in RN (n=13). All athletes had two induced sputum analyses at one- to two-week intervals in random order: after a period of 72 hours without training, 24 hours after a training session. RESULTS: PC20 was unchanged after training. The median % neutrophils and eosinophils in groups SH, SN, RH, and RN, respectively, were 26.5-1.6, 8.6-0.3, 28.0-0.03 and 25.5-0.1 before and 45.0-0.5, 31.1-0.4, 54.0-0.6 and 48.3-0.3 after training. While the magnitude of the increase in neutrophils was similar for all groups, it reached statistical significance (pre-post-training) only in the SH group (P = 0.039). CONCLUSION: A one-hour session of high-intensity training was associated with an increase in airway neutrophils among hyperresponsive swimmer athletes, while airway responsiveness remained unchanged in all groups.

Functional classes of bronchial mucosa genes that are differentially expressed in asthma.

BACKGROUND: Asthma pathogenesis and susceptibility involves a complex interplay between genetic and environmental factors. Their interaction modulates the airway inflammation and remodelling processes that are present even in mild asthma and governs the appearance and severity of symptoms of airway hyperresponsiveness. While asthma is felt to develop as the result of interaction among many different genes and signalling pathways, only a few genes have been linked to an increased risk of developing this condition. RESULTS: We report the results of expression microarray studies using tissue obtained from bronchial biopsies of healthy controls and of subjects with allergic asthma, both before and following inhaled corticotherapy. We identified 79 genes that show significant differences in expression (following Bonferroni cutoff using p < 6.6 x 10(-6) to correct for multiple testing) in asthmatics compared to controls at significance levels. These included 21 genes previously implicated in asthma, such as NOS2A and GPX3, as well as new potential candidates, such as ALOX15, CTSC and CX3CR1. The expression levels of one third of these transcripts were partially or completely corrected following inhaled corticosteroid therapy. CONCLUSION: The study shows that bronchial biopsies obtained from healthy and asthmatic subjects display distinct expression profiles. These differences provide a global view of physiopathologic processes active in the asthmatic lung and may provide invaluable help to clarify the natural history of asthma.